Results 171 to 180 of about 118,029,410 (206)
Some of the next articles are maybe not open access.
EMC - Ginecología-Obstetricia, 2021
Resumen El carcinoma ductal in situ (CDIS) se define como una proliferacion de celulas malignas en los conductos galactoforos, sin que atraviesen la membrana basal. El CDIS representa alrededor el 10-15% del conjunto de los canceres mamarios. Su tratamiento tiene por objetivo prevenir el desarrollo de un cancer infiltrante y, a la vez, evitar un ...
C. Mathelin +4 more
openaire +1 more source
Resumen El carcinoma ductal in situ (CDIS) se define como una proliferacion de celulas malignas en los conductos galactoforos, sin que atraviesen la membrana basal. El CDIS representa alrededor el 10-15% del conjunto de los canceres mamarios. Su tratamiento tiene por objetivo prevenir el desarrollo de un cancer infiltrante y, a la vez, evitar un ...
C. Mathelin +4 more
openaire +1 more source
1996
In the past 10 years clinical trials have confirmed the value of breast conserving therapy for invasive breast cancer and many authorities now consider this the preferred and appropriate treatment (NCI Consensus Statement 1992a). However controversy still surrounds the treatment of ductal carcinoma in situ (DCIS).
openaire +2 more sources
In the past 10 years clinical trials have confirmed the value of breast conserving therapy for invasive breast cancer and many authorities now consider this the preferred and appropriate treatment (NCI Consensus Statement 1992a). However controversy still surrounds the treatment of ductal carcinoma in situ (DCIS).
openaire +2 more sources
Management of ductal carcinoma in situ
Surgical Oncology, 1994Ductal carcinoma in situ (DCIS) is an early, localized stage of breast carcinoma that has an excellent prognosis when it is properly treated. The significant increase in the frequency of diagnosis of DCIS in recent years is the result of both better recognition of DCIS among pathologists and widespread use of screening mammography.
M P, Vezeridis, K I, Bland
openaire +2 more sources
Ductal Carcinoma in Situ of the Breast
Annals of Internal Medicine, 1997The increasing incidence and biological heterogeneity of ductal carcinoma in situ (DCIS) of the breast have made the management of this entity challenging and controversial. This paper reviews data on the natural history of the disease and results obtained with various management approaches.Computerized MEDLINE search of articles related to DCIS ...
R, Fonseca +5 more
openaire +2 more sources
Surgery for ductal carcinoma in Situ
Breast Cancer, 2000Ductal carcinomas in situ (DCIS) are sometimes treated too aggressively by surgery. We discuss minimal invasive surgery for DCIS on the basis of our experience at the Cancer Institute Hospital in Tokyo.We performed surgery for 667 cases of DCIS between 1987 to 1998.
K, Takahashi +8 more
openaire +2 more sources
Treatment of ductal carcinoma in situ
BMJ, 2011New data refine the risk estimates associated with various treatments As knowledge of the clinical and pathological subtypes of ductal carcinoma in situ (DCIS) grows, medical oncologists, surgical oncologists, and radiation oncologists have an increasingly complex task in diagnosing and treating this disease, and advising their patients on the best ...
openaire +2 more sources
Tamoxifen in Ductal Carcinoma In Situ
Seminars in Oncology, 2006The widespread adoption of screening mammography has resulted in an increased incidence of ductal carcinoma in situ (DCIS), which now accounts for 20% to 30% of new breast cancer diagnoses. Despite treatment with combined lumpectomy and radiation therapy, up to 15% of women will experience an ipsilateral breast recurrence, with 50% of these recurrences
openaire +2 more sources
Anastrozole for ductal carcinoma in situ
The Lancet, 2003Jack, Cuzick +3 more
openaire +2 more sources